Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CAR-T
CAR-T
Juno Therapeutics Could Nearly Double On Data, Multiple Catalysts
Benzinga
Tue, 08/18/15 - 04:16 pm
Juno Therapeutics
JCAR017
CAR-T
Heard the latest Kite Pharma rumor? CEO says it ain't so
Fierce Biotech
Mon, 08/17/15 - 10:14 am
Kite Pharma
KTE-C19
CAR-T
Biogen: Where Did That Come From?
Barron's
Fri, 07/3/15 - 11:16 am
Biogen
Applied Genetic Technologies
CAR-T
Cancer Therapy Boosts Appeal of Juno, Kite as Targets: Real M&A
Bloomberg
Wed, 06/24/15 - 08:29 am
Juno Therapeutics
Kite Pharma
M&A
cancer
CAR-T
Juno Therapeutics: The Future Of CAR-T Innovation
Seeking Alpha
Sat, 06/20/15 - 09:41 am
Juno Therapeutics
CAR-T
Celgene narrows pioneering CAR-T collaboration with bluebird bio, hands over $25M sweetener
Fierce Biotech
Thu, 06/4/15 - 12:04 pm
Celgene
CAR-T
Bluebird Bio
bb2121
AstraZeneca’s Soriot Open to Buying Immune-Therapy Company
Bloomberg
Tue, 06/2/15 - 04:36 pm
AstraZeneca
Pascal Soriot
M&A
CAR-T
Juno Therapeutics
Novartis, Juno Killer T-Cells Show Promise In Another Blood Cancer
Forbes
Tue, 06/2/15 - 09:05 am
Novartis
Juno Therapeutics
CAR-T
non-Hodgkin's lymphoma
CAR-T powerhouse Juno allies with gene-editing upstart Editas in $737M deal
Fierce Biotech
Wed, 05/27/15 - 09:57 am
Juno Therapeutics
CAR-T
gene editing
Editas Medicine
ASCO cancer research data drop: What to watch
CNBC
Wed, 05/13/15 - 12:18 pm
ASCO
oncology
cancer
Merck
Bristol-Myers Squibb
AstraZeneca
Juno Therapeutics
CAR-T
Ibrance
Pfizer
elotuzumab
Opdivo
Keytruda
Bellicum buys into CAR-T manufacturing amid a hot immuno-oncology race
Fierce Biotech
Fri, 05/8/15 - 11:09 am
Bellicum
CAR-T
immuno-oncology
What biopharma needs to know about CAR-T cancer therapies
BioPharma Dive
Sun, 04/26/15 - 09:21 am
CAR-T
Novartis
CTL019
Novartis solid tumor 'CAR T cell' still holds promise - researcher
Yahoo/Reuters
Tue, 04/21/15 - 09:21 am
Novartis
solid tumors
CAR-T
Novartis' new CAR-T hopeful looks safe in an early solid tumor study
Fierce Biotech
Mon, 04/20/15 - 11:53 am
Novartis
CAR-T
immuno-oncology
It's A Big Weekend For Biotech
Yahoo/Benzinga
Sat, 04/18/15 - 11:55 am
biotech
Biogen
BIIB037
RG7800
PTC Therapeutics
Alnylam
CAR-T
Merck
Bristol-Myers Squibb
Novartis
Juno Therapeutics
Bellicum
Juno and Novartis settle CAR-T patent fight with little fanfare
Fierce Biotech
Mon, 04/6/15 - 10:07 am
Juno Therapeutics
Novartis
patents
CAR-T
Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy
Yahoo
Mon, 03/30/15 - 11:11 am
Intrexon
Merck Serono
CAR-T
chimeric antigen receptor T-cell immunotherapies
Cellectis upscales IPO toward $200M as CAR-T fever continues
Fierce Biotech
Wed, 03/25/15 - 09:45 am
Cellectis
IPOs
CAR-T
This Billionaire CEO Just Made Another Biotech Acquisition -- and Hardly Anyone Noticed
Motley Fool
Sun, 03/1/15 - 11:32 am
Intrexon
CAR-T
Zogenix
ActoGeniX
Safety concerns cloud early promise of powerful new cancer drugs
Yahoo/Reuters
Mon, 01/26/15 - 08:12 am
cancer
CAR-T
Amgen
Celgene
Bluebird Bio
Novartis
Kite Pharma
Pfizer
Cellectis
Juno Therapeutics
Pages
« first
‹ previous
…
20
21
22
23
24
25
26
27
28
next ›
last »